He lands in favor of redistribution-like regulations that benefit newer startups and «those catching up,» while disadvantaging the more powerful frontier labs.
Open source models should also be vetted once they reach a certain level, as the White House has agreed to. Open source brings «specific risks,» he argues, although he doubts they will solve the distribution or concentration problem.
On AI’s generally negative public image lately, Amodei says this is fundamentally an issue of trust:
— I think that ordinary people don’t trust companies, governments, or the tech industry and always suspect that we are cooking up some new way to screw them over, he writes.
Continue reading “Amodei calls for better regulation, sees «early glimmers» on diseases soon”